OP20.01: An Independent Predictor for Methotrexate Resistance in Low-Risk Gestational Trophoblastic Neoplasia With Myometrial Invasion: A Prospective Study

Ultrasound in Obstetrics and Gynecology - United States
doi 10.1002/uog.17882
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Case of Methotrexate Resistant Gestational Trophoblastic Neoplasia

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2018English

The 16-Year Experience in Treating Low-Risk Gestational Trophoblastic Neoplasia Patients With Failed Primary Methotrexate Chemotherapy

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2020English

First Line Chemotherapy in Low Risk Gestational Trophoblastic Neoplasia

2008English

Efficacy and Risk Factors Associated to Resistance to Single-Agent Chemotherapy in Low-Risk Gestational Trophoblastic Neoplasia

Open Journal of Obstetrics and Gynecology
2016English

The Value of an Initial Drop in Human Chorionic Gonadotropin Levels in Predicting a Response to Methotrexate in Women With Low-Risk Gestational Trophoblastic Neoplasia

Ginekologia Polska
GynecologyObstetrics
2019English

A Rare Cause for Gestational Trophoblastic Neoplasia: Placental Site Trophoblastic Tumor

Open Journal of Obstetrics and Gynecology
2013English

Pulmonary Metastases Increase Chemotherapy Resistance and Recurrence of Gestational Trophoblastic Neoplasia

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2020English

Pembrolizumab Is Effective for Drug-Resistant Gestational Trophoblastic Neoplasia

The Lancet
Medicine
2017English

Macroscopic Hematuria as a Presentation of Gestational Trophoblastic Neoplasia in an Adolescent Woman

Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy